Abstract Supplementary Information: The online version contains supplementary material available at 10.1186/s13041-025-01255-1. Article type: Research Article Keywords: Anxiety, Cerebrolysin, Memory,…
Abstract Background: The objective of this study was to investigate the prevalence of discharge against medical advice (DAMA) among schizophrenia…
Abstract To date, no psychotropic medication has shown to effectively halt progression to psychosis among individuals at Clinical High-Risk for…
Abstract Background: The link between cannabis use and schizophrenia is well-established in epidemiological studies, especially among adolescents with early-onset use.…
Abstract Background: Given that antipsychotic medication is a cornerstone for treating and preventing relapse in people with schizophrenia, non-adherence has…
Abstract Introduction: The endocannabinoid (eCB) system disruption has been suggested to underpin the development of psychosis, fueling the search for…
Abstract This is a report of a 29-year-old female with a history of Schizophrenia and Cannabis Use Disorder who presented…
Abstract Introducción.: Los trastornos psicóticos se consideran problemas crónicos de salud mental. Aunque se ha demostrado que estos trastornos pueden…
Abstract Background: Psychotic disorders are associated with high rates of comorbid substance use disorders. Use of cannabis rich in tetrahydrocannabinol…
Abstract Background: People with schizophrenia are more likely to develop cannabis use disorder (CUD) and experience worse outcomes with use.…